Journal article
A randomized controlled trial to assess alendronate‐associated injury of the upper gastrointestinal tract
Abstract
BACKGROUND: Aminobisphosphonates are recommended for postmenopausal osteoporosis but have been associated with injury to the upper gastrointestinal tract.
AIM: To conduct a randomized controlled trial, to assess the endoscopic damage caused by alendronate and its effect on gastric mucosal prostaglandin synthesis.
Authors
Marshall JK; Rainsford KD; James C; Hunt RH
Journal
Alimentary Pharmacology & Therapeutics, Vol. 14, No. 11, pp. 1451–1457
Publisher
Wiley
Publication Date
November 27, 2000
DOI
10.1046/j.1365-2036.2000.00864.x
ISSN
0269-2813